Cervical Cancer: Basic Information and Comprehensive Control

Preview this chapter:

Cervical Cancer: Basic Information and Comprehensive Control, Page 1 of 1

< Previous page | Next page > /docserver/preview/fulltext/9789815256291/chapter-6-1.gif

Cervical cancer, which epidemiologically resembles a non-infectious form of venereal disease, is a predominant contributor to cancer-related deaths in females across the globe. The HPV-16 and HPV-18 strains of the human papillomavirus, as well as STDs, are the prime causes of cervical cancer. In low-income female communities, it ranks as the second most frequent malignancy. Primary, secondary, and tertiary preventative strategies are included for the management of cervix cancer. The primary defense against cervical cancer includes guarding against HPV infection. One of the key preventative strategies for cervical cancer involves immunizing females between the ages of 9 and 14 with the HPV vaccine before they begin sexual activity. Secondary cervical cancer prevention requires examination and a chemotherapy regimen. Testing asymptomatic females in the target population (pre-cancer risk for the cervix) is a component of determining the susceptibility to cervical carcinoma. Tertiary disease prevention includes the provision of palliative care and treatments for cervical cancer. Tertiary care encompasses surgical interventions, radiation treatment, chemotherapy, and supportive care for patients. To ensure that the community takes responsibility for preventing the incidences of cervical cancer, community mobilization, awareness of health, and counseling are essential. It is important to routinely monitor and assess key program indicators for cervical cancer prophylaxis and curb it.